Why are there bioprinters in space?

Share on facebook
Share on twitter
Share on linkedin

When it comes to space exploration, workplace hazards come with the territory. But why would researchers choose to work in space to improve treatment for patients on Earth?

It can be challenging to develop the vascular networks required for organ function. Typical bioinks have low viscosity at room temperature, and they solidify as they approach human body temperature. In the meantime, bioprinted structures need support so they don’t collapse. Researchers can use scaffolds to support thick tissues – but scaffolds can damage vascular networks.

 

Bioprinting without gravity eliminates the risk of collapse, enabling organs to grow without the need for any scaffolds. Some researchers believe that working in microgravity is the key to developing fully functional bioprinted organs.

 

NASA will test that theory in May 2019, when they’re scheduled to launch a BioFabrication Facility to the International Space Station.

 

“Our ultimate goal is to provide a solution to an organ shortage that causes an average of 20 people per day in the U.S. alone to die waiting for an organ transplant,” said Rich Boling, the project developer’s vice president of corporate advancement.

 

The team will start by completing test protocols, and is planning to start printing whole organs in 2025. After that, bringing them to the clinic could take another 10 years. And even though rockets cost tens of millions of dollars per mission, NASA’s organs are still expected to cost less than what patients pay to treat chronic disease.

More from Our Blog

Got collagen?

Being the most abundant protein in mammals has earned collagen a special status in tissue engineering labs. But recent global supply chain disruptions have made finding a reliable supplier a truly Herculean race against time.

Read More

What are spheroids and why are they important?

Share on facebook Share on twitter Share on linkedin Spheroids, the three-dimensional (3D) cell cultures that arrange themselves during proliferation into sphere-like formations, got their name in the 1970s, when scientists observed

Read More

More efficient drug screening with 3D bioprinting

Share on facebook Share on twitter Share on linkedin Taking a drug to market is a competitive, costly and challenging process involving preclinical laboratory and animal testing before the even more time-consuming and expensive four

Read More
BIO CELLX
BIO CELLX
See a video on how the system works in practice

Get the link to the full video below, or watch the abridged version on our Youtube channel.

BIO X6 - Demo

BIO X6 - Demo